JNJ Revenue Growth (YoY) Analysis

Revenue growth (YoY) of 6.6% means JNJ's revenue for the latest quarter is 6.6% higher than the same quarter last year.

That level exactly matches the sector median of 6.6%, but the stock sits at the 0th percentile among sector peers, meaning it ranks at the very bottom of the healthcare group on this metric. The trend data is incomplete: the year-over-year change is marked N/A, while the quarter-over-quarter change is -33.3% — the growth rate fell from 9.9% to 6.6% between the two most recent reported periods. A revenue growth rate that matches the sector average but is collapsing quarter over quarter points to increasing competitive pressure and a higher chance of underperformance ahead. This combination of a median-level current result with a sharp downward trajectory raises near-term investment risk rather than offering a clear opportunity. The metric directly supports the CAUTIOUS verdict, since decelerating growth at the bottom of the peer percentile is consistent with a watch-and-wait approach.

Frequently Asked Questions